Leaflet OSMOFUNDIN 150mg / ml solution for infusion

Indicated for: cerebral edema; edema; bronchial challenge test

Route of administration: infusion

Substance: mannitol (osmotic agent)

ATC: B05BC01 (Blood and blood forming organs | I.v. solutions | Solutions producing osmotic diuresis)

Mannitol is an osmotic diuretic primarily used to reduce intracranial and intraocular pressure. It is commonly used in emergency situations such as traumatic brain injuries or cerebral edema.

It works by increasing the excretion of water and electrolytes through the kidneys, thereby reducing fluid volume in the body. Mannitol is administered intravenously under medical supervision.

Side effects may include electrolyte imbalances, dehydration, or allergic reactions. It is important to monitor kidney function and electrolyte levels during treatment.

Mannitol is not recommended for patients with severe renal failure, severe dehydration, or active intracranial hemorrhage.

General data about OSMOFUNDIN 150mg / ml

  • Substance: mannitol
  • Date of latest medicines list: 01-06-2026
  • Product code: W08255009
  • Concentration: 150mg / ml
  • Pharmaceutical form: solution for infusion
  • Packing volume: 250ml
  • Product type: Original
  • Price: 483.97 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: B. BRAUN MELSUNGEN AG - GERMANIA
  • Holder: B. BRAUN MELSUNGEN AG - GERMANIA
  • Number: 8247/2015/09
  • Shelf life: 3 years

Concentrations available for mannitol

  • 10%
  • 150mg/ml
  • 20%
  • 200g/1000ml
  • 200g/l
  • 20g/100ml